Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
SAP SE €103.62 €120.00
Gazprom ADR €5.03 €7.00
Alibaba Group Holding Ltd ADR €202.00 €250.00
Security Price Target price
Ocugen Inc. €1.91 €0.000
The9 Ltd ADR ? -
SES S.A. €7.59 €25.00

Pros and Cons of these stocks (New Predictions)

Nio Inc.

WKN: A2N4PB / Name: Nio Inc. / Stock / ?

Pros
1
Strong uniques
1
Medium risks for its business
1
Sustainability is very important
Cons
1
Low dividend yield expected
1
Risky balance sheet
1
overvalued
DBV Technologies S.A.

WKN: A1JWB7 / Name: DBV Tech / Stock / Pharmaceuticals / Small Cap

Pros
1
Top 10 in its market
1
Could be worthwhile Investment >10% per year
1
Future proof or reliable business model
Cons
1
negative Cash Flow expected
1
Little known brand
1
Significant cyclical dependencies
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops

Security Price Change(%) (%)
Flowserve Corp. €30.40 5.560%
Akamai Tech. €88.03 4.130%
C.H. Robinson Worldwide Inc. €80.00 3.900%
Nisource Inc. €18.70 3.890%
Abiomed Inc. €271.60 3.760%
Security Price Change(%) (%)
Wells Fargo & Co. €26.74 -6.440%
EOG Resources Inc. €48.60 -5.630%
Citigroup Inc. €53.57 -5.600%
Cboe Holdings Inc. €78.71 -5.450%
Helmerich & Payne Inc €21.60 -5.260%

Top Indices (Indication)

Security Price % Buy Sell Target price Potential
Dow Jones 30,864
18:19
-0.450% 5 1 34,600 12.105%
S&P 500 3,775.0
18:19
-0.580% 5 4 3,325.0 -11.921%
FTSE 100 6,733.0
18:19
-0.880% 0 4 3,503.0 -47.973%
Nikkei 225 28,365
18:19
-1.900% 6 0 31,500 11.052%

Courses

Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.
sharewise Introduction:
sharewise Introduction
This is a course about the functionalities of sharewise. You will learn about the basics and how to best use the platform.

Predictions

buy
T-Mobile US Inc.

Start price
Target price
Perf. (%)
€103.46
€115.00
1.45%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
PVA TePla AG

Start price
Target price
Perf. (%)
€16.70
€28.00
1.08%

DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
-
7.42%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Farfetch Ltd

Start price
Target price
Perf. (%)
€49.82
€50.00
-4.07%

Future proof or reliable business model
Known brand
Top 10 in its market
Could be worthwhile Investment >10% per year

Top News

News

Nanobiotix Announces Positive First Results for Novel NBTXR3 in Rectal Cancer Study at ASCO-GI 2021: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix Announces Positive First Results for Novel NBTXR3 in Rectal Cancer Study at ASCO-GI 2021


NANOBIOTIX (Paris:NANO) (NASDAQ:NBTX) (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company”), a clinical-stage biotechnology company focused on developing first-in-class product candidates that use

Puma Biotechnology Presents Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT “Basket” Trial of Neratinib at ASCO GI : https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg
Puma Biotechnology Presents Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT “Basket” Trial of Neratinib at ASCO GI


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced interim results from the biliary tract cancers cohort of the ongoing SUMMIT trial of neratinib at the virtual 2021

Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston : https://mms.businesswire.com/media/20200203005819/en/720533/5/CC_CORPORATE_-01.jpg
Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston


Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today it was awarded a provisional license from the Massachusetts Cannabis Control

Eaton to Announce Fourth Quarter 2020 Earnings on February 2, 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24410/Eaton_Color_logo.png
Eaton to Announce Fourth Quarter 2020 Earnings on February 2, 2021


Power management company Eaton (NYSE:ETN) will announce fourth quarter 2020 earnings on Tuesday, February 2, 2021, before the opening of the New York Stock Exchange. The company will host a

Eurofins, the global leader in analytical testing, expands worldwide face mask testing & certification capabilities: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins, the global leader in analytical testing, expands worldwide face mask testing & certification capabilities


Since the start of the pandemic Eurofins  (Paris:ERF) has tested thousands of models of surgical and hygienic masks and provided best-in-class speed and certification for PPEs globally, enabling

Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2


The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral

Hill Holliday Bets Big on 2021: https://mms.businesswire.com/media/20210114006080/en/852543/5/IcaroDoriapicHillHolliday.jpg
Hill Holliday Bets Big on 2021


Hill Holliday, an award-winning, full service creative advertising agency is betting big on 2021 as they name award-winning creative, Icaro Doria as Chief Creative Officer.


This press release

Pioneer Natural Resources Announces Pricing of Public Offering of $750.0 Million of 0.750% Senior Notes Due 2024, $750.0 Million of 1.125% Senior Notes Due 2026 and $1.0 Billion of 2.150% Senior Notes Due 2031: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24709/Pioneer_Natural_Resources_logo.png
Pioneer Natural Resources Announces Pricing of Public Offering of $750.0 Million of 0.750% Senior Notes Due 2024, $750.0 Million of 1.125% Senior Notes Due 2026 and $1.0 Billion of 2.150% Senior Notes Due 2031


Pioneer Natural Resources Company (NYSE:PXD) (“Pioneer” or “the Company”) today announced that it has priced a public offering of $750.0 million of 0.750% Senior Notes that will mature January 15

Washington Federal Announces Quarterly Earnings Per Share Of $0.51 : https://mms.businesswire.com/media/20200114005879/en/747281/5/WaFdBank_logo_horiz_stack_rgb.jpg
Washington Federal Announces Quarterly Earnings Per Share Of $0.51


Washington Federal, Inc. (Nasdaq: WAFD) (the "Company"), parent company of Washington Federal Bank, N.A. ("WaFd Bank"), today announced quarterly earnings of $38,951,000 or $0.51 per diluted share

Contest

Compete in Catch the Monkey ...

... and win a prize!